"Designing Growth Strategies is in our DNA"

Coagulation Factors Market Size, Share & Industry Analysis, By Type (Factor IX, Factor VIII, Prothrombin Complex Concentrates, Fibrinogen Concentrates, and Others), By Application (Immunology & Neurology, Hematology, Critical Care, and Others), By End User (Hospitals & Clinics, Clinical Research Laboratories, and Others), and Regional Forecast, 2025-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI112621

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Epidemiology of Bleeding Disorders
    2. New Product Launches, By Key Players
    3. Key Industry Developments Such as Mergers, Acquisitions, and Collaborations
    4. Impact of Tariff on the Market
  5. Global Coagulation Factors Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Factor IX
      2. Factor VIII
      3. Prothrombin Complex Concentrates
      4. Fibrinogen Concentrates
      5. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Immunology & Neurology
      2. Hematology
      3. Critical Care
      4. Others
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Clinics
      2. Clinical Research Laboratories
      3. Others
    4. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Coagulation Factors Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Factor IX
      2. Factor VIII
      3. Prothrombin Complex Concentrates
      4. Fibrinogen Concentrates
      5. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Immunology & Neurology
      2. Hematology
      3. Critical Care
      4. Others
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Clinics
      2. Clinical Research Laboratories
      3. Others
    4. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Coagulation Factors Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Factor IX
      2. Factor VIII
      3. Prothrombin Complex Concentrates
      4. Fibrinogen Concentrates
      5. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Immunology & Neurology
      2. Hematology
      3. Critical Care
      4. Others
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Clinics
      2. Clinical Research Laboratories
      3. Others
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Coagulation Factors Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Factor IX
      2. Factor VIII
      3. Prothrombin Complex Concentrates
      4. Fibrinogen Concentrates
      5. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Immunology & Neurology
      2. Hematology
      3. Critical Care
      4. Others
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Clinics
      2. Clinical Research Laboratories
      3. Others
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Coagulation Factors Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Factor IX
      2. Factor VIII
      3. Prothrombin Complex Concentrates
      4. Fibrinogen Concentrates
      5. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Immunology & Neurology
      2. Hematology
      3. Critical Care
      4. Others
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Clinics
      2. Clinical Research Laboratories
      3. Others
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Coagulation Factors Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Factor IX
      2. Factor VIII
      3. Prothrombin Complex Concentrates
      4. Fibrinogen Concentrates
      5. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Immunology & Neurology
      2. Hematology
      3. Critical Care
      4. Others
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Clinics
      2. Clinical Research Laboratories
      3. Others
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. GCC
      2. South Africa
      3. Rest of Middle East & Africa 
  11. Competitive Analysis
    1. Global Market Share Analysis (2024)
    2. Company Profiles
      1. CSL
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. Takeda Pharmaceutical Company Limited
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Kedrion S.p.A.
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Octapharma AG
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. LFB
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Bayer AG
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Epidemiology of Bleeding Disorders
    2. New Product Launches, By Key Players
    3. Key Industry Developments Such as Mergers, Acquisitions, and Collaborations
    4. Impact of Tariff on the Market
  5. Global Coagulation Factors Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Factor IX
      2. Factor VIII
      3. Prothrombin Complex Concentrates
      4. Fibrinogen Concentrates
      5. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Immunology & Neurology
      2. Hematology
      3. Critical Care
      4. Others
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Clinics
      2. Clinical Research Laboratories
      3. Others
    4. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Coagulation Factors Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Factor IX
      2. Factor VIII
      3. Prothrombin Complex Concentrates
      4. Fibrinogen Concentrates
      5. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Immunology & Neurology
      2. Hematology
      3. Critical Care
      4. Others
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Clinics
      2. Clinical Research Laboratories
      3. Others
    4. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Coagulation Factors Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Factor IX
      2. Factor VIII
      3. Prothrombin Complex Concentrates
      4. Fibrinogen Concentrates
      5. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Immunology & Neurology
      2. Hematology
      3. Critical Care
      4. Others
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Clinics
      2. Clinical Research Laboratories
      3. Others
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Coagulation Factors Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Factor IX
      2. Factor VIII
      3. Prothrombin Complex Concentrates
      4. Fibrinogen Concentrates
      5. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Immunology & Neurology
      2. Hematology
      3. Critical Care
      4. Others
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Clinics
      2. Clinical Research Laboratories
      3. Others
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Coagulation Factors Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Factor IX
      2. Factor VIII
      3. Prothrombin Complex Concentrates
      4. Fibrinogen Concentrates
      5. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Immunology & Neurology
      2. Hematology
      3. Critical Care
      4. Others
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Clinics
      2. Clinical Research Laboratories
      3. Others
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Coagulation Factors Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Factor IX
      2. Factor VIII
      3. Prothrombin Complex Concentrates
      4. Fibrinogen Concentrates
      5. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Immunology & Neurology
      2. Hematology
      3. Critical Care
      4. Others
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Clinics
      2. Clinical Research Laboratories
      3. Others
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. GCC
      2. South Africa
      3. Rest of Middle East & Africa 
  11. Competitive Analysis
    1. Global Market Share Analysis (2024)
    2. Company Profiles
      1. CSL
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. Takeda Pharmaceutical Company Limited
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Kedrion S.p.A.
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Octapharma AG
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. LFB
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Bayer AG
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Figure 1: Global Coagulation Factors Market Revenue Breakdown (USD billion, %) by Region, 2024 & 2032

Figure 2: Global Coagulation Factors Market Value Share (%), by Type, 2024 & 2032

Figure 3: Global Coagulation Factors Market Value Share (%), by Application, 2024 & 2032

Figure 4: Global Coagulation Factors Market Value Share (%), by End User, 2024 & 2032

Figure 5: Global Coagulation Factors Market Value (USD billion), by Region, 2024 & 2032

Figure 6: North America Coagulation Factors Market Value (USD billion), by Type, 2024 & 2032

Figure 7: North America Coagulation Factors Market Value Share (%), by Type, 2024

Figure 8: North America Coagulation Factors Market Value (USD billion), by Application, 2024 & 2032

Figure 9: North America Coagulation Factors Market Value Share (%), by Application, 2024

Figure 10: North America Coagulation Factors Market Value (USD billion), by End User, 2024 & 2032

Figure 11: North America Coagulation Factors Market Value Share (%), by End User, 2024

Figure 12: North America Coagulation Factors Market Value (USD billion), By Country, 2024 & 2032

Figure 13: North America Coagulation Factors Market Value Share (%), By Country, 2024

Figure 14: Europe Coagulation Factors Market Value (USD billion), by Type, 2024 & 2032

Figure 15: Europe Coagulation Factors Market Value Share (%), by Type, 2024

Figure 16: Europe Coagulation Factors Market Value (USD billion), by Application, 2024 & 2032

Figure 17: Europe Coagulation Factors Market Value Share (%), by Application, 2024

Figure 18: Europe Coagulation Factors Market Value (USD billion), by End User, 2024 & 2032

Figure 19: Europe Coagulation Factors Market Value Share (%), by End User, 2024

Figure 20: Europe Coagulation Factors Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 21: Europe Coagulation Factors Market Value Share (%), By Country/ Sub-region, 2024

Figure 22: Asia Pacific Coagulation Factors Market Value (USD billion), by Type, 2024 & 2032

Figure 23: Asia Pacific Coagulation Factors Market Value Share (%), by Type, 2024

Figure 24: Asia Pacific Coagulation Factors Market Value (USD billion), by Application, 2024 & 2032

Figure 25: Asia Pacific Coagulation Factors Market Value Share (%), by Application, 2024

Figure 26: Asia Pacific Coagulation Factors Market Value (USD billion), by End User, 2024 & 2032

Figure 27: Asia Pacific Coagulation Factors Market Value Share (%), by End User, 2024

Figure 28: Asia Pacific Coagulation Factors Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 29: Asia Pacific Coagulation Factors Market Value Share (%), By Country/ Sub-region, 2024

Figure 30: Latin America Coagulation Factors Market Value (USD billion), by Type, 2024 & 2032

Figure 31: Latin America Coagulation Factors Market Value Share (%), by Type, 2024

Figure 32: Latin America Coagulation Factors Market Value (USD billion), by Application, 2024 & 2032

Figure 33: Latin America Coagulation Factors Market Value Share (%), by Application, 2024

Figure 34: Latin America Coagulation Factors Market Value (USD billion), by End User, 2024 & 2032

Figure 35: Latin America Coagulation Factors Market Value Share (%), by End User, 2024

Figure 36: Latin America Coagulation Factors Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 37: Latin America Coagulation Factors Market Value Share (%), By Country/ Sub-region, 2024

Figure 38: Middle East & Africa Coagulation Factors Market Value (USD billion), by Type, 2024 & 2032

Figure 39: Middle East & Africa Coagulation Factors Market Value Share (%), by Type, 2024

Figure 40: Middle East & Africa Coagulation Factors Market Value (USD billion), by Application, 2024 & 2032

Figure 41: Middle East & Africa Coagulation Factors Market Value Share (%), by Application, 2024

Figure 42: Middle East & Africa Coagulation Factors Market Value (USD billion), by End User, 2024 & 2032

Figure 43: Middle East & Africa Coagulation Factors Market Value Share (%), by End User, 2024

Figure 44: Middle East & Africa Coagulation Factors Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 45: Middle East & Africa Coagulation Factors Market Value Share (%), By Country/ Sub-region, 2024

Figure 46: Global Coagulation Factors Market Share (%), By Company, 2024

Table 1: Global Coagulation Factors Market Revenue (USD billion) Forecast, by Type, 2019–2032

Table 2: Global Coagulation Factors Market Revenue (USD billion) Forecast, by Application, 2019–2032

Table 3: Global Coagulation Factors Market Revenue (USD billion) Forecast, by End User, 2019–2032

Table 4: Global Coagulation Factors Market Revenue (USD billion) Forecast, by Region, 2019-2032

Table 5: North America Coagulation Factors Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 6: North America Coagulation Factors Market Revenue (USD billion) Forecast, by Application, 2019-2032

Table 7: North America Coagulation Factors Market Revenue (USD billion) Forecast, by End User, 2019-2032

Table 8: North America Coagulation Factors Market Revenue (USD billion) Forecast, By Country, 2019-2032

Table 9: Europe Coagulation Factors Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 10: Europe Coagulation Factors Market Revenue (USD billion) Forecast, by Application, 2019-2032

Table 11: Europe Coagulation Factors Market Revenue (USD billion) Forecast, by End User, 2019-2032

Table 12: Europe Coagulation Factors Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 13: Asia Pacific Coagulation Factors Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 14: Asia Pacific Coagulation Factors Market Revenue (USD billion) Forecast, by Application, 2019-2032

Table 15: Asia Pacific Coagulation Factors Market Revenue (USD billion) Forecast, by End User, 2019-2032

Table 16: Asia Pacific Coagulation Factors Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 17: Latin America Coagulation Factors Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 18: Latin America Coagulation Factors Market Revenue (USD billion) Forecast, by Application, 2019-2032

Table 19: Latin America Coagulation Factors Market Revenue (USD billion) Forecast, by End User, 2019-2032

Table 20: Latin America Coagulation Factors Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 21: Middle East & Africa Coagulation Factors Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 22: Middle East & Africa Coagulation Factors Market Revenue (USD billion) Forecast, by Application, 2019-2032

Table 23: Middle East & Africa Coagulation Factors Market Revenue (USD billion) Forecast, by End User, 2019-2032

Table 24: Middle East & Africa Coagulation Factors Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

  • 2019-2032
  • 2024
  • 2019-2023
  • 150
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann